Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new medicines set out in the Schedule hereto:
Schedule
Product: Demazin 12 Hour Relief Nasal Spray
Active Ingredient: Oxymetazoline hydrochloride 0.5mg/mL
Dosage Form: Nasal spray solution
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: CPL Contract Pharmaceuticals Limited, Ontario, Canada
Product: Dimetapp Saline Nasal drops
Active Ingredient: Sodium chloride 7.04mg/mL
Dosage Form: Nasal drops
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product: Dimetapp Saline Nasal spray
Active Ingredient: Sodium chloride 7.04mg/mL
Dosage Form: Nasal spray solution
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product: Sudafed PE Phenylephrine Night
Active Ingredients: Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg equivalent to Phenylephrine 4.1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturers: Johnson & Johnson Pty Limited, Cape Town, South Africa
Janssen-Cilag, Val de Reuil, France
Dated this 1st day of May 2014.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister
of Health on 11 September 2013).